Tech Center 1600 • Art Units: 1632
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17426467 | RNA-TARGETING CAS ENZYMES | Non-Final OA | The Regents of the University of California |
| 17262460 | Treatment of Vascular Occlusion by Activation of Notch Signaling | Non-Final OA | The Regents of the University of California |
| 17842715 | CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS | Final Rejection | Genentech, Inc. |
| 17616283 | APPLICATION OF ANTIARRHYTHMIC AGENTS TO STEM CELL DERIVED CARDIOMYOCYTES AND USES THEREOF | Final Rejection | Novo Nordisk A/S |
| 17424529 | IN VITRO HUMAN BLOOD BRAIN BARRIER | Non-Final OA | Massachusetts Institute of Technology |
| 17250791 | METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF | Non-Final OA | Beth Israel Deaconess Medical Center, Inc. |
| 17802577 | PRODUCTION METHOD OF RETINAL PIGMENT EPITHELIAL CELL | Non-Final OA | RIKEN |
| 17048289 | INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTICAL SPHEROIDS | Final Rejection | Case Western Reserve University |
| 17738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17430131 | GENERATION OF HUMAN PLURIPOTENT STEM CELL DERIVED ARTIFICIAL TISSUE STRUCTURES WITHOUT THREE DIMENSIONAL MATRICES | Non-Final OA | MILTENYI BIOTEC B.V. & CO. KG |
| 17863785 | HIGH-DENSITY CELL CULTURE METHOD | Final Rejection | AJINOMOTO CO., INC. |
| 17610124 | EXTRACELLULAR MATRIX MATERIAL AND USES THEREOF | Non-Final OA | The Chinese University of Hong Kong |
| 18171832 | METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS | Non-Final OA | TOPPAN Inc. |
| 17924687 | INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE | Non-Final OA | YANGZHOU UNIVERSITY |
| 18757662 | Renal Progenitor Cells | Non-Final OA | The University of Queensland |
| 17611241 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | Non-Final OA | Rutgers, The State University of New Jersey |
| 17272204 | MEDIUM COMPOSITION FOR SUSPENSION CULTURE OF ADHESIVE CELLS | Final Rejection | NISSAN CHEMICAL CORPORATION |
| 17310007 | FIBROBLAST REGENERATIVE CELLS | Non-Final OA | Figene, LLC |
| 17309649 | THERAPEUTIC USES OF GENE EDITED FIBROBLASTS | Non-Final OA | Figene, LLC |
| 17052859 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | Final Rejection | Figene, LLC |
| 18028156 | MINI-BRAIN STRUCTURE AND CONSTRUCTION METHOD THEREFOR | Non-Final OA | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION |
| 17606644 | SYNTHETIC SELF-REPLICATING RNA VECTORS ENCODING CRISPR PROTEINS AND USES THEREOF | Non-Final OA | EMD Millipore Corporation |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | Final Rejection | The Council of the Queensland Institute of Medical Research |
| 17421161 | System and method for cryopreservation of tissues | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE |
| 17779275 | METHODS OF REPROGRAMMING A CELL | Final Rejection | MONASH UNIVERSITY |
| 17436374 | POROUS CELLULAR SCAFFOLD COMPRISING SERUM-DERIVED PROTEIN, AND PRODUCTION METHOD THEREFOR | Non-Final OA | DANAGREEN CO., LTD. |
| 17501716 | PORCINE SEXED SEMEN AND METHODS OF USE | Final Rejection | ABS Global, Inc. |
| 17273143 | BIOMATERIAL COMPRISING ADIPOSE-DERIVED STEM CELLS AND GELATIN AND METHOD FOR PRODUCING THE SAME | Non-Final OA | NOVADIP BIOSCIENCES |
| 17605714 | TREATMENT OF KIDNEY DISEASE IN SUBJECTS WITH KIDNEY AND/OR URINARY TRACT ANOMALIES | Non-Final OA | ProKidney |
| 18195223 | COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY | Non-Final OA | Jerome Canady Research Institute for Advanced Biological and Technological Sciences |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy